4.7 Review

Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer's disease

Related references

Note: Only part of the references are listed.
Review Genetics & Heredity

CDiP technology for reverse engineering of sporadic Alzheimer's disease

Takayuki Kondo et al.

Summary: Alzheimer's disease is a neurodegenerative disease with unknown exact causes. The cellular dissection of polygenicity technology has helped identify potential therapeutic targets and polygenes for predicting real-world AD. This technology holds promising future perspectives for reverse engineering sporadic AD.

JOURNAL OF HUMAN GENETICS (2023)

Article Clinical Neurology

Lecanemab, Aducanumab, and Gantenerumab - Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease

Linda Soderberg et al.

Summary: Immunotherapy targeting amyloid-beta (A ss) shows promise in treating Alzheimer's disease (AD). This study characterized the binding properties of three antibodies (lecanemab, aducanumab, and gantenerumab) to various A ss species and found different binding preferences, which may explain the variability in clinical efficacy and side effects observed for these antibodies.

NEUROTHERAPEUTICS (2023)

Article Clinical Neurology

Lecanemab, Aducanumab, and Gantenerumab - Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease

Linda Soderberg et al.

Summary: The study revealed different binding profiles of lecanemab, aducanumab, and gantenerumab to various species of Aβ, which may explain the varying clinical outcomes and side effects observed for these antibodies.

NEUROTHERAPEUTICS (2023)

Article Biotechnology & Applied Microbiology

The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics

Eric Karran et al.

Summary: Clinical trial data for drugs targeting Aβ in Alzheimer's disease suggest that reducing amyloid plaque to a low level may reveal significant clinical benefit, but there may be a time lag between plaque removal and observable clinical benefit. The speed of amyloid removal from the brain by a potential therapy will be crucial in demonstrating clinical benefit in a clinical trial setting.

NATURE REVIEWS DRUG DISCOVERY (2022)

Article Cell Biology

Neural stem cell transplantation alleviates functional cognitive deficits in a mouse model of tauopathy

He-Ao Zhang et al.

Summary: This study transplanted neural stem cells into the hippocampal CA1 region of a mouse model to investigate the mechanisms of their effect on Alzheimer's disease. The results showed that the transplantation reduced tau aggregation and improved short-term memory. Changes in protein expression related to tau aggregation regulation were observed. These findings provide insights into the functional capacity of neural stem cell transplantation in Alzheimer's disease treatment.

NEURAL REGENERATION RESEARCH (2022)

Article Cell Biology

Human neural cell type-specific extracellular vesicle proteome defines disease-related molecules associated with activated astrocytes in Alzheimer's disease brain

Yang You et al.

Summary: In this study, the proteomic profiles of EVs derived from different types of neural cells were investigated. Cell type-specific EV protein markers were identified, and the role of astrocyte-specific EVs in Alzheimer's disease (AD) progression was explored. The hub protein ITGB1 was found to be significantly elevated in astrocyte-specific EVs and associated with AD pathology.

JOURNAL OF EXTRACELLULAR VESICLES (2022)

Review Geriatrics & Gerontology

Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer's Disease: A Focus on Aducanumab and Lecanemab

Mingchao Shi et al.

Summary: Alzheimer's disease is the most prevalent form of age-related dementia in the world, with limited treatment options available to provide only partial symptomatic relief. Disease-modifying therapies, targeting the systemic failure of cell-mediated Aβ clearance, are currently being studied in clinical trials.

FRONTIERS IN AGING NEUROSCIENCE (2022)

Review Clinical Neurology

APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches

Alberto Serrano-Pozo et al.

Summary: The APOE ε4 allele and ε2 allele are respectively the strongest genetic risk factor and protective factor for Alzheimer's disease. While therapies targeting APOE are currently unavailable, recent research has expanded our understanding of APOE pathogenesis to include multiple pathological processes, offering valuable insights for therapy development.

LANCET NEUROLOGY (2021)

Article Biochemical Research Methods

Stem-cell-derived human microglia transplanted into mouse brain to study human disease

Nicola Fattorelli et al.

Summary: This study describes a method for studying human microglia in the mouse brain, combining in vitro differentiation and in vivo xenotransplantation protocols. This optimized approach offers higher efficiency and faster speed, achieving up to 80% chimerism.

NATURE PROTOCOLS (2021)

Article Neurosciences

Fully defined human pluripotent stem cell-derived microglia and tri-culture system model C3 production in Alzheimer's disease

Sudha R. Guttikonda et al.

Summary: The study utilizes a human pluripotent stem cell-derived tri-culture system to model neuroinflammation in Alzheimer's disease and identifies the critical role of reciprocal signaling between microglia and astrocytes in exacerbating the inflammatory response.

NATURE NEUROSCIENCE (2021)

Article Cell Biology

APOE4 disrupts intracellular lipid homeostasis in human iPSC-derived glia

Grzegorz Sienski et al.

Summary: The APOE gene's E4 allele is a genetic risk factor for cardiovascular diseases and Alzheimer's disease, but its mechanism of action is poorly understood. A study found that APOE4 disrupted cellular lipidomes, leading to increased unsaturation of fatty acids and intracellular lipid droplet accumulation. Supplementation with choline restored the cellular lipidome in APOE4-expressing cells, suggesting that manipulating lipid metabolism could be a therapeutic approach for individuals with the APOE4 allele.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Cell & Tissue Engineering

Generation of gene edited hiPSC from familial Alzheimer's disease patient carrying N141I missense mutation in presenilin 2

Hany E. Marei et al.

Summary: This study generated hiPSC from skin fibroblasts of an AD patient carrying a N141I missense mutation in PSEN2 and corrected the mutation using genome editing technology. The N141I missense mutation was associated with increased basal cell death and apoptosis.

STEM CELL RESEARCH (2021)

Article Clinical Neurology

Human neural stem cell-derived extracellular vesicles mitigate hallmarks of Alzheimer's disease

Lauren A. Apodaca et al.

Summary: The study demonstrated the regenerative potential of EVs derived from human neural stem cells in mitigating neurocognitive and neuropathologic hallmarks of Alzheimer's disease. The EV treatment showed neuroprotective effects in restoring fear extinction memory, reducing anxiety, decreasing amyloid plaque accumulation, and protecting against synaptic loss in the AD brain. MiRNA analysis of the EV cargo revealed promising candidates targeting neuroinflammation and synaptic function.

ALZHEIMERS RESEARCH & THERAPY (2021)

Article Geriatrics & Gerontology

Intranasal Transplantation of Human Neural Stem Cells Ameliorates Alzheimer's Disease-Like Pathology in a Mouse Model

Mei-Hong Lu et al.

Summary: The study demonstrated that intranasal delivery of human neural stem cells showed positive effects in Alzheimer's disease by improving pathological damages and rescuing cognitive function in transgenic mice.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Article Cell Biology

Infusion of hESC derived Immunity-and-matrix regulatory cells improves cognitive ability in early-stage AD mice

Jing Liu et al.

Summary: The study demonstrated that peripheral administration of IMRCs significantly improved cognitive deficits in early-stage AD mice through tail vein injection, while no significant changes were observed in the ICV group. IMRCs inhibited inflammatory responses and reduced microglial activation in vivo.

CELL PROLIFERATION (2021)

Article Neurosciences

Intravenous administration of mesenchymal stem cells reduces Tau phosphorylation and inflammation in the 3xTg-AD mouse model of Alzheimer's disease

Amanda Ferreira Neves et al.

Summary: The study demonstrates that the timing and frequency of MSC injections can impact various aspects of AD-like neuropathology in the 3xTg-AD mouse model. Single-dose MSC injections in young mice reduced neuroinflammation, while multiple doses affected beta-secretase cleavage and tau phosphorylation. Multiple-dose MSC injections also showed differing effects on tau phosphorylation at different sites in young and old mice.

EXPERIMENTAL NEUROLOGY (2021)

Article Medicine, General & Internal

US FDA defends approval of Alzheimer's disease drug

Susan Jaffe

LANCET (2021)

Article Neurosciences

Amyloid-β precursor protein processing and oxidative stress are altered in human iPSC-derived neuron and astrocyte co-cultures carrying presenillin-1 gene mutations following spontaneous differentiation

Richard J. Elsworthy et al.

Summary: The study reveals the impact of PSEN1 gene mutations on AβPP processing and cellular redox status, demonstrating the potential of iPSC-derived neuron and astrocyte co-cultures as an early human model of fAD.

MOLECULAR AND CELLULAR NEUROSCIENCE (2021)

Article Neurosciences

Plaque-associated human microglia accumulate lipid droplets in a chimeric model of Alzheimer's disease

Christel Claes et al.

Summary: The study found that lipid droplet accumulation occurs in human DAM xMGs in Alzheimer's disease, but is reduced in TREM2-R47H DAM xMGs, as it is caused by TREM2-mediated changes in plaque proximity and reactivity.

MOLECULAR NEURODEGENERATION (2021)

Article Multidisciplinary Sciences

Astrocytic interleukin-3 programs microglia and limits Alzheimer's disease

Cameron S. McAlpine et al.

Summary: Communication within the glial cell ecosystem is essential for neuronal and brain health. This study demonstrates that astrocyte-sourced interleukin-3 programs microglia to ameliorate the pathology of Alzheimer's disease by enhancing their ability to clear aggregates of beta-amyloid and tau, ultimately restricting disease progression and cognitive decline. These findings highlight IL-3 as a key mediator of astrocyte-microglia cross-talk and a potential therapeutic target for Alzheimer's disease.

NATURE (2021)

Article Neurosciences

Stem cell-derived neurons reflect features of protein networks, neuropathology, and cognitive outcome of their aged human donors

Valentina N. Lagomarsino et al.

Summary: This resource includes iPSC lines from 53 individuals, coupled with RNA and proteomic profiling of both iPSC-derived neurons and brain tissue. Analysis of iPSC neurons revealed associations between specific Ab and tau species and cognitive decline, as well as identified proteins and networks associated with AD phenotypes.

NEURON (2021)

Article Cell Biology

Wolframin-1-expressing neurons in the entorhinal cortex propagate tau to CA1 neurons and impair hippocampal memory in mice

Jean-Christophe Delpech et al.

Summary: The study shows that in early stages of Alzheimer's disease, Wfs1(+) neurons in the ECII region are associated with abnormally phosphorylated tau, leading to the spread of tau and potential functional abnormalities in CA1 pyramidal neurons.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Cell Biology

In vivo and neuropathology data support locus coeruleus integrity as indicator of Alzheimer's disease pathology and cognitive decline

Heidi I. L. Jacobs et al.

Summary: Various autopsy studies have shown that the locus coeruleus (LC) is the initial site of hyperphosphorylated TAU aggregation, and as TAU accumulates in LC neurons, pathology spreads throughout the cortex. Lower LC integrity is associated with increased TAU deposition in the entorhinal cortex in older individuals, and LC pigmentation ratings correlate with LC neuronal density, particularly in advanced Braak stages. These findings suggest that LC integrity may be a promising indicator of early Alzheimer's disease processes and cognitive changes.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Multidisciplinary Sciences

Improved modeling of human AD with an automated culturing platform for iPSC neurons, astrocytes and microglia

Reina Bassil et al.

Summary: Researchers have developed an automated long-term culturing platform for human iPSC neurons, astrocytes, and microglia to model cellular aspects of Alzheimer's disease.

NATURE COMMUNICATIONS (2021)

Article Cell & Tissue Engineering

Potential application of human neural crest-derived nasal turbinate stem cells for the treatment of neuropathology and impaired cognition in models of Alzheimer's disease

Jung Yeon Lim et al.

Summary: This study validated the potential of human neural crest-derived nasal turbinate stem cells (hNTSCs) as a clinically promising therapeutic source for Alzheimer's disease treatment. Results showed that hNTSC transplantation significantly reduced A beta 42 levels and plaque formation, increased neuronal survival, and improved cognition in an AD mouse model, indicating a promising therapeutic effect for AD patients.

STEM CELL RESEARCH & THERAPY (2021)

Article Cell & Tissue Engineering

Icariin Promotes Survival, Proliferation, and Differentiation of Neural Stem Cells In Vitro and in a Rat Model of Alzheimer's Disease

Denglei Ma et al.

Summary: The study suggests that icariin can promote the survival, proliferation, and differentiation of neural stem cells in the basal forebrain, increasing the number of cholinergic neurons. This combination therapy may offer a new potential and effective approach for Alzheimer's disease treatment.

STEM CELLS INTERNATIONAL (2021)

Article Biochemistry & Molecular Biology

Mesenchymal Stem Cell-Derived Exosomes Ameliorate Alzheimer's Disease Pathology and Improve Cognitive Deficits

Yi-An Chen et al.

Summary: The study evaluated the therapeutic performance of MSC-exosomes in AD, showing that they could reduce Aβ expression, restore the expression of neuronal memory/synaptic plasticity-related genes, improve brain glucose metabolism and cognitive function in AD transgenic mice.

BIOMEDICINES (2021)

Review Cell Biology

Potential effects of mesenchymal stem cell derived extracellular vesicles and exosomal miRNAs in neurological disorders

Masako Nakano et al.

Summary: Mesenchymal stem cells have potential therapeutic effects on neurological disorders by secreting paracrine factors and exosomal microRNAs. Studies have shown that these substances can improve neuronal dysfunction in models of various neurological disorders.

NEURAL REGENERATION RESEARCH (2021)

Article Geriatrics & Gerontology

Intracerebral Transplantation of Neural Stem Cells Restores Manganese-Induced Cognitive Deficits in Mice

Huijuan Shu et al.

Summary: The study suggests that direct intracerebral transplantation of neural stem cells can improve cognitive function in mice exposed to manganese, possibly by enhancing neurogenesis in the host brain and providing a potential cellular basis for cognitive improvement. This research underscores the potential of treating manganese exposure through NSC transplantation.

AGING AND DISEASE (2021)

Review Biotechnology & Applied Microbiology

Genome Editing in iPSC-Based Neural Systems: From Disease Models to Future Therapeutic Strategies

Amy McTague et al.

Summary: Therapeutic advances for neurological disorders face challenges, but the use of iPSC technology and genome editing can create more precise disease models and identify new therapeutic targets.

FRONTIERS IN GENOME EDITING (2021)

Article Cell Biology

Therapeutic potential of dental pulp stem cell transplantation in a rat model of Alzheimer's disease

Xue-Mei Zhang et al.

Summary: Dental pulp stem cells derived from the neural crest show potential for treating nervous system diseases. Transplantation of these cells in rat models of Alzheimer's disease led to increased expression of neuron-related proteins in the hippocampus, decreased expression of amyloid-beta, and improved cognitive and behavioral abilities. The findings suggest a potential therapeutic effect of dental pulp stem cell transplantation for Alzheimer's disease.

NEURAL REGENERATION RESEARCH (2021)

Review Biochemistry & Molecular Biology

Modeling Alzheimer's disease with iPSC-derived brain cells

Jay Penney et al.

MOLECULAR PSYCHIATRY (2020)

Review Geriatrics & Gerontology

Differences Between Human and Murine Tau at the N-terminal End

Felix Hernandez et al.

FRONTIERS IN AGING NEUROSCIENCE (2020)

Review Neurosciences

The Use of Patient-Derived Induced Pluripotent Stem Cells for Alzheimer's Disease Modeling

Christopher Lee et al.

PROGRESS IN NEUROBIOLOGY (2020)

Article Cell Biology

Mesenchymal stem cell-derived exosomal miR-223 regulates neuronal cell apoptosis

Hong Wei et al.

CELL DEATH & DISEASE (2020)

Article Multidisciplinary Sciences

Amyloid-β42/40 ratio drives tau pathology in 3D human neural cell culture models of Alzheimer's disease

Sang Su Kwak et al.

NATURE COMMUNICATIONS (2020)

Article Multidisciplinary Sciences

LRP1 is a master regulator of tau uptake and spread

Jennifer N. Rauch et al.

NATURE (2020)

Article Multidisciplinary Sciences

Reversing a model of Parkinson's disease with in situ converted nigral neurons

Hao Qian et al.

NATURE (2020)

Review Genetics & Heredity

Alzheimer's Disease Genetics: Review of Novel Loci Associated with Disease

Miguel Tabuas-Pereira et al.

CURRENT GENETIC MEDICINE REPORTS (2020)

Article Neurosciences

Differentiation and maturation of oligodendrocytes in human three-dimensional neural cultures

Rebecca M. Marton et al.

NATURE NEUROSCIENCE (2019)

Article Multidisciplinary Sciences

Individual brain organoids reproducibly form cell diversity of the human cerebral cortex

Silvia Velasco et al.

NATURE (2019)

Article Medicine, General & Internal

Aberrant axon branching via Fos-B dysregulation in FUS-ALS motor neurons

Tetsuya Akiyama et al.

EBIOMEDICINE (2019)

Article Medicine, General & Internal

CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia

Lei Xu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Clinical Neurology

Impaired serine metabolism complements LRRK2-G2019S pathogenicity in PD patients

Sarah Louise Nickels et al.

PARKINSONISM & RELATED DISORDERS (2019)

Article Multidisciplinary Sciences

Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain

Devon S. Svoboda et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Cell & Tissue Engineering

PSEN1ΔE9, APPswe, and APOE4 Confer Disparate Phenotypes in Human iPSC-Derived Microglia

Henna Konttinen et al.

STEM CELL REPORTS (2019)

Review Cell Biology

Physiological and pathological effects of amyloid-β species in neural stem cell biology

Adela Bernabeu-Zornoza et al.

NEURAL REGENERATION RESEARCH (2019)

Review Cell & Tissue Engineering

Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities

Jacques Galipeau et al.

CELL STEM CELL (2018)

Review Clinical Neurology

Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

Melanie D. Sweeney et al.

NATURE REVIEWS NEUROLOGY (2018)

Review Multidisciplinary Sciences

The CRISPR tool kit for genome editing and beyond

Mazhar Adli

NATURE COMMUNICATIONS (2018)

Review Neurosciences

Reconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease

Fuyuki Kametani et al.

FRONTIERS IN NEUROSCIENCE (2018)

Article Cell & Tissue Engineering

The Impact of APP on Alzheimer-like Pathogenesis and Gene Expression in Down Syndrome iPSC-Derived Neurons

Dmitry A. Ovchinnikov et al.

STEM CELL REPORTS (2018)

Article Biochemical Research Methods

Induction of myelinating oligodendrocytes in human cortical spheroids

Mayur Madhavan et al.

NATURE METHODS (2018)

Article Multidisciplinary Sciences

Noggin rescues age-related stem cell loss in the brain of senescent mice with neurodegenerative pathology

Maria Diaz-Moreno et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Cell & Tissue Engineering

Protein-Induced Pluripotent Stem Cells Ameliorate and Reduce Aβ Deposition of Alzheimer's Disease

Moon-Yong Cha et al.

STEM CELLS TRANSLATIONAL MEDICINE (2017)

Article Biochemistry & Molecular Biology

APOE ε4/ε4 diminishes neurotrophic function of human iPSC-derived astrocytes

Jing Zhao et al.

HUMAN MOLECULAR GENETICS (2017)

Review Clinical Neurology

Alzheimer's Disease: Past, Present, and Future

Mark W. Bondi et al.

JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2017)

Editorial Material Multidisciplinary Sciences

Presenilin-1 mutations and Alzheimer's disease

Raymond J. Kelleher et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Multidisciplinary Sciences

Rapid and efficient generation of oligodendrocytes from human induced pluripotent stem cells using transcription factors

Marc Ehrlich et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Multidisciplinary Sciences

MHC matching improves engraftment of iPSC-derived neurons in non-human primates

Asuka Morizane et al.

NATURE COMMUNICATIONS (2017)

Article Cell & Tissue Engineering

Cell-type Dependent Alzheimer's Disease Phenotypes: Probing the Biology of Selective Neuronal Vulnerability

Christina R. Muratore et al.

STEM CELL REPORTS (2017)

Article Multidisciplinary Sciences

Astrocyte pathology in a human neural stem cell model of frontotemporal dementia caused by mutant TAU protein

Anna-Lena Hallmann et al.

SCIENTIFIC REPORTS (2017)

Review Biochemistry & Molecular Biology

Tau mis-splicing in the pathogenesis of neurodegenerative disorders

Sun Ah Park et al.

BMB REPORTS (2016)

Review Biochemistry & Molecular Biology

The Cellular Phase of Alzheimer's Disease

Bart De Strooper et al.

Review Cell & Tissue Engineering

Genome Editing in Human Pluripotent Stem Cells: Approaches, Pitfalls, and Solutions

William T. Hendriks et al.

CELL STEM CELL (2016)

Review Medicine, Research & Experimental

The amyloid hypothesis of Alzheimer's disease at 25years

Dennis J. Selkoe et al.

EMBO MOLECULAR MEDICINE (2016)

Article Chemistry, Medicinal

Gamma Secretase Modulators: New Alzheimer's Drugs on the Horizon?

Matthew G. Bursavich et al.

JOURNAL OF MEDICINAL CHEMISTRY (2016)

Article Neurosciences

Neuronal activity enhances tau propagation and tau pathology in vivo

Jessica W. Wu et al.

NATURE NEUROSCIENCE (2016)

Article Biotechnology & Applied Microbiology

Uncovering the novel characteristics of Asian honey bee, Apis cerana, by whole genome sequencing

Doori Park et al.

BMC GENOMICS (2015)

Review Pharmacology & Pharmacy

An analysis of FDA-approved drugs for neurological disorders

Michael S. Kinch

DRUG DISCOVERY TODAY (2015)

Article Cell Biology

Human Olfactory Bulb Neural Stem Cells Mitigate Movement Disorders in a Rat Model of Parkinson's Disease

Hany E. S. Marei et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2015)

Review Clinical Neurology

Prion-like transmission and spreading of tau pathology

F. Clavaguera et al.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2015)

Article Cell Biology

APP Metabolism Regulates Tau Proteostasis in Human Cerebral Cortex Neurons

Steven Moore et al.

CELL REPORTS (2015)

Review Neurosciences

The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration

Yong-Bo Hu et al.

TRANSLATIONAL NEURODEGENERATION (2015)

Article Biochemistry & Molecular Biology

The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons

Christina R. Muratore et al.

HUMAN MOLECULAR GENETICS (2014)

Review Biochemistry & Molecular Biology

Tau Protein Modifications and Interactions: Their Role in Function and Dysfunction

Anna Mietelska-Porowska et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)

Article Neurosciences

Subregional Basal Forebrain Atrophy in Alzheimer's Disease: A Multicenter Study

Ingo Kilimann et al.

JOURNAL OF ALZHEIMERS DISEASE (2014)

Review Neurosciences

Models of β-amyloid induced Tau-pathology: the long and folded road to understand the mechanism

Ilie-Cosmin Stancu et al.

MOLECULAR NEURODEGENERATION (2014)

Article Biochemistry & Molecular Biology

Pharmacological chaperones stabilize retromer to limit APP processing

Vincent J. Mecozzi et al.

NATURE CHEMICAL BIOLOGY (2014)

Article Clinical Neurology

Amyloid-β and Tau The Trigger and Bullet in Alzheimer Disease Pathogenesis

George S. Bloom

JAMA NEUROLOGY (2014)

Article Biotechnology & Applied Microbiology

Medial ganglionic eminence-like cells derived from human embryonic stem cells correct learning and memory deficits

Yan Liu et al.

NATURE BIOTECHNOLOGY (2013)

Article Multidisciplinary Sciences

Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathy

Andrea Serio et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Review Neurosciences

Origin and differentiation of microglia

Florent Ginhoux et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2013)

Article Biochemistry & Molecular Biology

MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies

Daniah Trabzuni et al.

HUMAN MOLECULAR GENETICS (2012)

Article Multidisciplinary Sciences

Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells

Mason A. Israel et al.

NATURE (2012)

Review Neurosciences

The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes

Iryna Benilova et al.

NATURE NEUROSCIENCE (2012)

Editorial Material Multidisciplinary Sciences

iPSC Disease Modeling

Frank Soldner et al.

SCIENCE (2012)

Article Medicine, Research & Experimental

The Clinical Problem of Symptomatic Alzheimer Disease and Mild Cognitive Impairment

Rawan Tarawneh et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)

Article Medicine, Research & Experimental

Biochemistry of Amyloid β-Protein and Amyloid Deposits in Alzheimer Disease

Colin L. Masters et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)

Article Medicine, Research & Experimental

Trafficking and Proteolytic Processing of APP

Christian Haass et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)

Review Neurosciences

Amyloid Precursor Protein Processing and Alzheimer's Disease

Richard J. O'Brien et al.

ANNUAL REVIEW OF NEUROSCIENCE, VOL 34 (2011)

Letter Biotechnology & Applied Microbiology

Knockout rats generated by embryo microinjection of TALENs

Laurent Tesson et al.

NATURE BIOTECHNOLOGY (2011)

Review Cell Biology

Alzheimer's Disease: The Challenge of the Second Century

David M. Holtzman et al.

SCIENCE TRANSLATIONAL MEDICINE (2011)

Article Medicine, Research & Experimental

Neuropathological Alterations in Alzheimer Disease

Alberto Serrano-Pozo et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)

Review Neurosciences

An Overview of APP Processing Enzymes and Products

Vivian W. Chow et al.

NEUROMOLECULAR MEDICINE (2010)

Article Clinical Neurology

Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects

Leslie M. Shaw et al.

ANNALS OF NEUROLOGY (2009)

Article Multidisciplinary Sciences

Knockout Rats via Embryo Microinjection of Zinc-Finger Nucleases

Aron M. Geurts et al.

SCIENCE (2009)

Article Biochemistry & Molecular Biology

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

Kazutoshi Takahashi et al.

Article Clinical Neurology

Epidemiology and risk factors of dementia

WM van der Flier et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)

Article Biochemistry & Molecular Biology

Stimulation of homologous recombination through targeted cleavage by chimeric nucleases

M Bibikova et al.

MOLECULAR AND CELLULAR BIOLOGY (2001)